慢性高血压患者妊娠并发症与孕前心脏结构功能相关
这项前瞻性观察队列研究纳入192例接受治疗的慢性高血压患者,孕前进行超声心动图评估心脏形态与功能。结果显示孕前左室重构和舒张功能障碍与早发型和晚发型妊娠并发症相关,孕前使用钙通道阻滞剂和/或ACEI/ARB可能改善心脏特征并降低并发症率。
要点
- 孕前左室几何构型改变、舒张功能障碍是妊娠并发症的独立预测因素。
- 向心性重构多见于早发型并发症,离心性肥厚多见于晚发型并发症。
- 孕前使用钙通道阻滞剂和/或ACEI/ARB可能与较低并发症率相关。
核心结论
- 孕前存在心脏重构和功能障碍的慢性高血压患者更易发生早发型和晚发型妊娠并发症。
- 孕前使用钙通道阻滞剂和/或ACEI/ARB可能对心脏特征和妊娠结局产生积极影响并降低并发症率。
研究设计与样本
- 前瞻性观察性队列研究,连续纳入192例接受治疗的慢性高血压患者。
- 孕前进行超声心动图评估左心室形态与功能、心输出量和总血管阻力。
- 孕前治疗包括钙通道阻滞剂、ACEI/ARB、β受体阻滞剂、α1肾上腺素受体拮抗剂和/或利尿剂,孕前改为α甲基多巴并随访至分娩。
主要发现
- 192例中141例无并发症,51例发生妊娠并发症(24例早发型,27例晚发型)。
- 向心性构型在早发型并发症中更常见(50% vs 晚发型13.5%和无并发症11.1%,P<.05)。
- 离心性肥厚在晚发型并发症中更常见(32% vs 早发型12.5%和无并发症1.4%,P<.05)。
- 单因素分析中,左室几何构型改变OR 5.94(95%CI 2.90-12.19),舒张功能障碍OR 3.22(95%CI 1.63-6.37),总血管阻力改变OR 3.52(95%CI 1.78-6.97),孕前未用CCB/ACEI/ARB的OR 2.73(95%CI 1.37-5.42)。
- 多因素分析校正BMI、心率、产次和平均动脉压后,除总血管阻力改变外,其余参数均为独立预测因素。
关键数值与推荐
- E/e'比值>7.65预测后续妊娠并发症,敏感性59.6%,特异性68.6%。
- 总血管阻力<1048预测晚发型并发症,敏感性83.7%,特异性55.6%。
- 总血管阻力>1498预测早发型并发症,敏感性87.5%,特异性78.0%。
临床怎么用
- 对慢性高血压计划妊娠患者,孕前可考虑超声心动图评估心脏结构和功能以识别高危人群。
- 孕前使用钙通道阻滞剂和/或ACEI/ARB可能与降低妊娠并发症风险相关,但需在孕前转换为α甲基多巴。
- 孕前E/e'比值和总血管阻力可作为风险分层参考指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic hypertension complicates around 3% of all pregnancies and is associated with an increased risk for pregnancy complications such as superimposed preeclampsia, fetal growth restriction, preterm delivery, and stillbirth, reaching a rate of complications of up to 25-28%. OBJECTIVE: We performed an echocardiographic study to evaluate pre-pregnancy cardiac geometry and function, along with the hemodynamic features of treated chronic hypertension patients, searching for a possible correlation with the development of feto-maternal complications and with pre-pregnancy therapy. MATERIALS AND METHODS: This was a prospective observational cohort study of 192 consecutive patients receiving treatment for chronic hypertension (calcium channel blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers, α1-adrenoceptor antagonists, and/or diuretics). Patients underwent echocardiography before pregnancy, assessing left ventricular morphology and function, cardiac output, and total vascular resistance. Pre-pregnancy therapy was noted, patients were shifted to α-methyldopa right before pregnancy, and were followed until delivery, noting major early (<34weeks' gestation) and late (≥34 weeks' gestation) complications. Comparisons among the 3 groups (ie, those with no complications, early complications, and late complications) were performed with 1-way analysis of variance with Student-Newman-Keuls correction for multiple comparisons. The Mann-Whitney U test was used for non-normally distributed data. Comparison of proportions was used as appropriate. Receiver operating characteristic curve analysis was used to identify cutoff values of diastolic dysfunction in this population using the E/e' ratio, and separate cutoff of values for total vascular resistance for the prediction of early and late complications of pregnancy. Binary univariate and multivariate logistic regression as well as Cox proportional hazards regression were used to evaluate the possible correlation among angiotensin-converting enzyme inhibitor/angiotensin receptor blocker and/or calcium channel blocker pre-pregnancy therapy, cardiovascular features, and the risk for subsequent early and late complications of pregnancy. RESULTS: Of 192 patients, 141 had no complications, and 51 had a complicated pregnancy (24 had early complications and 27 had late complications). Concentric geometry was more frequent in those women with early versus late and no complications (50% vs 13.5% and 11.1%, respectively; P < .05), whereas eccentric hypertrophy was more represented in women with late versus early and no complications (32% versus 12.5% and 1.4%, respectively; P < .05). The receiver operating characteristic curve showed an E/e' ratio value >7.65 (sensitivity, 59.6%; specificity, 68.6%) as a predictor of subsequent complications of pregnancy, whereas total vascular resistance <1048 (sensitivity, 83.7%; specificity, 55.6%) was predictive for late complications and total vascular resistance >1498 (sensitivity, 87.5%; specificity, 78.0%) for the early complications of pregnancy. Univariate analysis showed that the following parameters were predictive for complications of pregnancy: altered geometry of the left ventricle (odds ratio, 5.94; 95% confidence interval, 2.90-12.19), diastolic dysfunction (odds ratio, 3.22; 95% confidence interval, 1.63-6.37), altered total vascular resistance (odds ratio, 3.52; 95% confidence interval, 1.78-6.97), and pre-pregnancy therapy without calcium channel blockers/angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (odds ratio, 2.73; 95% confidence interval, 1.37-5.42). These parameters, except for altered total vascular resistance, were independent predictors in the multivariate analysis corrected for body mass index, heart rate, parity, and mean arterial pressure. CONCLUSION: Chronic hypertension patients with pre-pregnancy cardiac remodeling and dysfunction more often develop early and late complications of pregnancy. Pre-pregnancy therapy for chronic hypertension patients with calcium channel blockers and/or angiotensin-converting enzyme inhibitors/angiotensin receptor blockers may positively influence cardiac profiles and the outcome of a future pregnancy with a reduced rate of complications.
引用
- Vasapollo B, Novelli GP, Gagliardi G, et al. Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure. Am J Obstet Gynecol. 2020. PMID: 32142824. doi:10.1016/j.ajog.2020.02.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。